In focus · trending topic

clinical-stage

16 stories · following the connections

Ocera to Present at the Cowen and Company 37th Annual Healthcare Conference

By Nasdaq OMXFeb 28, 2017, 9:05 PM UTC

Ocera Announces Top-line Results for Phase 2b Study in Hepatic Encephalopathy

By Nasdaq OMXJan 30, 2017, 12:00 PM UTC

Ocera Therapeutics Appoints Biopharmaceutical Veteran Willard Dere, M.D. to Board of Directors

By Nasdaq OMXOct 28, 2016, 1:05 PM UTC

Ocera Therapeutics Announces Late-Breaker Abstract Accepted for Presentation at the AASLD Liver Meeting 2016

By Nasdaq OMXOct 24, 2016, 1:05 PM UTC

Ocera to Present at the 2016 BIO Investor Forum

By Nasdaq OMXOct 10, 2016, 8:05 PM UTC

Ocera to Present at the Ladenburg Thalmann 2nd Annual Healthcare Conference

By Nasdaq OMXSep 20, 2016, 1:10 PM UTC

Ocera Initiates Phase 1 Clinical Study of Orally Available OCR-002 in Patients with Cirrhosis for the Prevention of Hepatic Encephalopathy

By Nasdaq OMXSep 19, 2016, 1:05 PM UTC

Ocera Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate Update

By Nasdaq OMXMar 3, 2016, 2:05 PM UTC